On April 18, 2018, an extended board meeting of Russian Ministry of Industry and Trade was held featuring Deputy Prime ...

During April and May 2018, experts and leaders of the ChemRar Group will conduct a series of workshops on various ...

ChemRar Group took part in the first pharmaceutical subgroup joint meeting of the Russian-Italian task force on ...

The “ChemRar Center for Development of Innovative and Import-substituting Drugs” project was approved in 2009 by the ...

Russian innovative infrastructure, science and business leaders gathered at the third Congress of NeuroNet Industrial ...

The winners of the sixth annual National Rating of Russian High-Tech Rapidly Developing Companies TechUspekh-2017, ...

The Award Ceremony for the domestic pharmaceutical and medical industry institutional awards of the Ministry of ...

In early November, IPHARMA, a company of ChemRar Group, received two approvals from the Ministry of Healthcare of the ...

On November 14–16, the 21st Russian Oncology Congress was held in Moscow. It is the largest international event in the ...

October 30, 20017. IPHARMA, a company of ChemRar Group, was authorized by the Ministry of Healthcare of the Russian ...

On November 8 at 11 a.m., IPHARMA, a company of ChemRar Group, will conduct a webinar on the topic “Opportunities for ...

Technopark SKOLKOVO held a panel discussion on the topics “Civilization is (not) at risk in an age of artificial ...